UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM 6-K
_________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2024
Commission File Number 001-41661
_________________
JIN MEDICAL INTERNATIONAL LTD.
(Registrant’s name)
_________________
No. 33 Lingxiang Road, Wujin District
Changzhou City, Jiangsu Province
People’s Republic of China
(Address of principal executive office)
_________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Jin Medical International Ltd. | ||||
By: | /s/ Erqi Wang | |||
Name: | Erqi Wang | |||
Title: | Chief Executive Officer and Director |
Date: January 11, 2024
1
EXHIBIT INDEX
Exhibit No. | Description | |
99.1 | ||
99.2 |
2